A Study of HRS9531 in Participants With Impaired Kidney Function and Healthy Subjects

Clinical trial NCT06246175 · COMPLETED

Trial details

NCT number: NCT06246175
Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Type 2 Diabetes

Start date: 2024-02-28
Primary completion: 2025-09-02
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.